Cancer Letters
Volume 291, Issue 2 , Pages 158-166 , 28 May 2010

BmKCT toxin inhibits glioma proliferation and tumor metastasis

Received 1 September 2009 ,Revised 9 October 2009 ,Accepted 13 October 2009.

References 

  1. Hatta S, Sakamoto J, Horio Y. Ion channels and diseases. Med. Electron Microsc. 2002;35:117–126
  2. Nguyen TP, Wang DW, Rhodes TH, George AL. Divergent biophysical defects caused by mutant sodium channels in dilated cardiomyopathy with arrhythmia. Circ. Res. 2008;102:364–371
  3. Zucca C, Redaelli F, Epifanio R, Zanotta N, Romeo A, Lodi M, et al. Cryptogenic epileptic syndromes related to SCN1A: twelve novel mutations identified. Arch. Neurol. 2008;65:489–494
  4. Sokolov S, Scheuer T, Catterall WA. Gating pore current in an inherited ion channelopathy. Nature. 2007;446:76–78
  5. Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez-Marmol R, Sole L, et al. Potassium channels: new targets in cancer therapy. Cancer Detect. Prev. 2006;30:375–385
  6. Soroceanu L, Manning TJ, Sontheimer H. Modulation of glioma cell migration and invasion using Cl(−) and K(+) ion channel blockers. J. Neurosci. 1999;19:5942–5954
  7. Eder C. Regulation of microglial behavior by ion channel activity. J. Neurosci. Res. 2005;81:314–321
  8. Camerino DC, Tricarico D, Desaphy JF. Ion channel pharmacology. Neurotherapeutics. 2007;4:184–198
  9. Lightbown ID, Johnson M, Davis A, Leaney J, Leishman DJ. Towards automation of a valuable preclinical cardiac safety pharmacology assay: evaluation of the effects of cardiac ion channel blockers on cardiac repolarisation in vitro. J. Pharmacol. Toxicol. Methods. 2007;56:194–202
  10. Greene JG, Porter RH, Greenamyre JT. ARL-15896, a novel N-methyl-d-aspartate receptor ion channel antagonist: neuroprotection against mitochondrial metabolic toxicity and regional pharmacology. Exp. Neurol. 1996;137:66–72
  11. Lewis RJ, Garcia ML. Therapeutic potential of venom peptides. Nat. Rev. Drug. Discov. 2003;2:790–802
  12. Estrada G, Villegas E, Corzo G. Spider venoms: a rich source of acylpolyamines and peptides as new leads for CNS drugs. Nat. Prod. Rep. 2007;24:145–161
  13. Terlau H, Olivera BM. Conus venoms: a rich source of novel ion channel-targeted peptides. Physiol. Rev. 2004;84:41–68
  14. Trans Molecular receives FDA approval for 131-I-TM-601 IND application. Expert Rev. Anticancer Ther. 2 (2002) 139.
  15. MacKinnon R, Miller C. Mutant potassium channels with altered binding of charybdotoxin, a pore-blocking peptide inhibitor. Science. 1989;245:1382–1385
  16. Zhijian C, Feng L, Yingliang W, Xin M, Wenxin L. Genetic mechanisms of scorpion venom peptide diversification. Toxicon. 2006;47:348–355
  17. Goudet C, Chi CW, Tytgat J. An overview of toxins and genes from the venom of the Asian scorpion Buthus martensi Karsch. Toxicon. 2002;40:1239–1258
  18. Prevarskaya N, Skryma R, Bidaux G, Flourakis M, Shuba Y. Ion channels in death and differentiation of prostate cancer cells. Cell Death Differ. 2007;14:1295–1304
  19. Roger S, Potier M, Vandier C, Besson P, Le Guennec JY. Voltage-gated sodium channels: new targets in cancer therapy?. Curr. Pharm. Des. 2006;12:3681–3695
  20. Le Guennec JY, Ouadid-Ahidouch H, Soriani O, Besson P, Ahidouch A, Vandier C. Voltage-gated ion channels, new targets in anti-cancer research. Recent Patents Anticancer Drug Discov. 2007;2:189–202
  21. Schonherr R. Clinical relevance of ion channels for diagnosis and therapy of cancer. J. Membr. Biol. 2005;205:175–184
  22. Mao J, Chen L, Xu B, Wang L, Li H, Guo J, et al. Suppression of ClC-3 channel expression reduces migration of nasopharyngeal carcinoma cells. Biochem. Pharmacol. 2008;75:1706–1716
  23. Mamelak AN, Jacoby DB. Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin. Drug Deliv. 2007;4:175–186
  24. Liu T, Pang XY, Jiang F, Bai ZT, Ji YH. Anti-nociceptive effects induced by intrathecal injection of BmK AS, a polypeptide from the venom of Chinese-scorpion Buthus martensi Karsch, in rat formalin test. J. Ethnopharmacol. 2008;117:332–338
  25. Mamelak AN, Rosenfeld S, Bucholz R, Raubitschek A, Nabors LB, Fiveash JB, et al. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J. Clin. Oncol. 2006;24:3644–3650
  26. Li, Comp. Mater. Med., 1596.
  27. Zeng XC, Li WX, Zhu SY, Peng F, Zhu ZH, Wu KL, et al. Cloning and characterization of a cDNA sequence encoding the precursor of a chlorotoxin-like peptide from the Chinese scorpion Buthus martensii Karsch. Toxicon. 2000;38:1009–1014
  28. Deshane J, Garner CC, Sontheimer H. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J. Biol. Chem. 2003;278:4135–4144
  29. Wang WX, Ji YH. Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro. J. Neurooncol. 2005;73:1–7
  30. Fu YJ, Yin LT, Liang AH, Zhang CF, Wang W, Chai BF, et al. Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neurosci. Lett. 2007;412:62–67
  31. McConahey PJ, Dixon FJ. Radioiodination of proteins by the use of the chloramine-T method. Methods Enzymol. 1980;70:210–213
  32. Yoshida J, Mizuno M, Fujii M, Kajita Y, Nakahara N, Hatano M, et al. Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes. Human Gene. Ther. 2004;15:77–86
  33. Olsen ML, Schade S, Lyons SA, Amaral MD, Sontheimer H. Expression of voltage-gated chloride channels in human glioma cells. J. Neurosci. 2003;23:5572–5582
  34. Yamamoto M, Ueno Y, Hayashi S, Fukushima T. The role of proteolysis in tumor invasiveness in glioblastoma and metastatic brain tumors. Anticancer Res. 2002;22:4265–4268
  35. Hadziahmetovic M, Lo SS, Clarke JW, Farace E, Cavaliere R. Palliative treatment of poor prognosis patients with malignant gliomas. Expert Rev. Anticancer Ther. 2008;8:125–132
  36. Liotta LA, Stetler-Stevenson WG, Steeg PS. Cancer invasion and metastasis: positive and negative regulatory elements. Cancer Invest. 1991;9:543–551
  37. Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA, Strongin A. Matrix metalloproteinase-2 activation modulates glioma cell migration. J. Cell Sci. 1997;110(Pt 19):2473–2482
  38. McFerrin MB, Sontheimer H. A role for ion channels in glioma cell invasion. Neuron Glia Biol. 2006;2:39–49
  39. Ullrich N, Bordey A, Gillespie GY, Sontheimer H. Expression of voltage-activated chloride currents in acute slices of human gliomas. Neuroscience. 1998;83:1161–1173
  40. Ullrich N, Gillespie GY, Sontheimer H. Human astrocytoma cells express a unique chloride current. Neuroreport. 1996;7:1020–1024
  41. Rui Y, Fang P, Hui L, Zhijian C, Wenxin L. Functional analysis of a gene encoding a chlorotoxin-like peptide derived from scorpion toxin. Chinese J. Biochem. Mol. Biol. 2005;21:19–23
  42. Fu YJ, Yin LT, Wang W, Chai BF, Liang AH. Synthesis, expression and purification of a type of chlorotoxin-like peptide from the scorpion, Buthus martensii Karsch, and its acute toxicity analysis. Biotechnol. Lett. 2005;27:1597–1603
  43. Barth RF, Yang W, Wu G, Swindall M, Byun Y, Narayanasamy S, et al. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. Proc. Natl. Acad. Sci. USA. 2008;105:17493–17497
  44. Levkoff LH, Marshall GP, Ross HH, Caldeira M, Reynolds BA, Cakiroglu M, et al. Bromodeoxyuridine inhibits cancer cell proliferation in vitro and in vivo. Neoplasia. 2008;10:804–816
  45. Ricci-Vitiani L, Pallini R, Larocca LM, Lombardi DG, Signore M, Pierconti F, et al. Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ. 2008;15:1491–1498
  46. Fiveash JB, Gillespie GY, Oliver PG, Zhou T, Belenky ML, Buchsbaum DJ. Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5. Int. J. Radiat. Oncol. Biol. Phys. 2008;71:507–516
  47. Wang J, Kim YS, Liu S. 99mTc-labeling of HYNIC-conjugated cyclic RGDfK dimer and tetramer using EDDA as coligand. Bioconjug. Chem. 2008;19:634–642
  48. Page GG, Fennelly AM, Littleton-Kearney MT, Ben-Eliyahu S. Male–female differences in the impact of beta-adrenoceptor stimulation on resistance to experimental metastasis: exploring the effects of age and gonadal hormone involvement. J. Neuroimmunol. 2008;193:113–119
  49. Wang Si-Ying YL-R, Bao-Tian Zhang, Ji Cheng. Effect of diethylstilbestrol (DES) on immune function of mice-bearing tumor and its anti-metastatic effect. Chinese Pharmacol. Bull. 1996;12:450–459

PII: S0304-3835(09)00633-8

doi: 10.1016/j.canlet.2009.10.011

Cancer Letters
Volume 291, Issue 2 , Pages 158-166 , 28 May 2010

Article Tools

* Image Usage & Resolution